# RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study

> **NCT05202808** · NA · COMPLETED · sponsor: **RxSight, Inc.** · enrollment: 500 (actual)

## Conditions studied

- Aphakia
- Cataract

## Interventions

- **DEVICE:** Light Adjustable lens (LAL) and Light Delivery Device (LDD)
- **DEVICE:** Control IOL

## Key facts

- **NCT ID:** NCT05202808
- **Lead sponsor:** RxSight, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-03
- **Primary completion:** 2024-09-11
- **Final completion:** 2024-12-16
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2025-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05202808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05202808, "RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05202808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*